{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:28:16Z","timestamp":1792790896338,"version":"4.5.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["G0C4220N"],"award-info":[{"award-number":["G0C4220N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["12B7423N"],"award-info":[{"award-number":["12B7423N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["I001322N"],"award-info":[{"award-number":["I001322N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["SMINF KA\/20\/085"],"award-info":[{"award-number":["SMINF KA\/20\/085"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C14\/21\/095"],"award-info":[{"award-number":["C14\/21\/095"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["IBOF\/25\/028"],"award-info":[{"award-number":["IBOF\/25\/028"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARF-23-1149740"],"award-info":[{"award-number":["AARF-23-1149740"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006283","name":"Federal Railroad Administration","doi-asserted-by":"publisher","award":["2024\/031"],"award-info":[{"award-number":["2024\/031"]}],"id":[{"id":"10.13039\/100006283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006283","name":"Federal Railroad Administration","doi-asserted-by":"publisher","award":["20240018"],"award-info":[{"award-number":["20240018"]}],"id":[{"id":"10.13039\/100006283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006283","name":"Federal Railroad Administration","doi-asserted-by":"publisher","award":["2022\/022"],"award-info":[{"award-number":["2022\/022"]}],"id":[{"id":"10.13039\/100006283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006283","name":"Federal Railroad Administration","doi-asserted-by":"publisher","award":["A2024033S"],"award-info":[{"award-number":["A2024033S"]}],"id":[{"id":"10.13039\/100006283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004497","name":"KU Leuven Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.tins.2025.05.007","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:27:22Z","timestamp":1749688042000},"page":"538-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Amyloid precursor protein carboxy-terminal fragments as catalyzers of endolysosomal dysfunction in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"48","author":[{"given":"C\u00e9line","family":"Vrancx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0150-9661","authenticated-orcid":false,"given":"Wim","family":"Annaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2025.05.007_bb0005","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tins.2025.05.007_bb0010","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tins.2025.05.007_bb0015","doi-asserted-by":"crossref","first-page":"771","DOI":"10.14283\/jpad.2023.123","article-title":"Lecanemab clarity AD: quality-of-life results from a randomized, double-blind Phase 3 Trial in early Alzheimer\u2019s disease","volume":"10","author":"Cohen","year":"2023","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.tins.2025.05.007_bb0020","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2261509","article-title":"Delivery of the BrainshuttleTM amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans","volume":"15","author":"Grimm","year":"2023","journal-title":"MAbs"},{"key":"10.1016\/j.tins.2025.05.007_bb0025","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1474-4422(25)00024-9","article-title":"Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer\u2019s disease: an open-label extension of the phase 2\/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial","volume":"24","author":"Bateman","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2025.05.007_bb0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamaneurol.2019.3988","article-title":"Efficacy and safety of lanabecestat for treatment of early and mild Alzheimer disease: the AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials","volume":"77","author":"Wessels","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tins.2025.05.007_bb0035","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archneurol.2012.2194","article-title":"Safety and tolerability of the \u03b3-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease","volume":"69","author":"Coric","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tins.2025.05.007_bb0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tins.2025.05.007_bb0045","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMc1813435","article-title":"Preliminary Results of a trial of atabecestat in preclinical Alzheimer\u2019s disease","volume":"380","author":"Henley","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tins.2025.05.007_bb0050","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","article-title":"Randomized trial of verubecestat for prodromal Alzheimer\u2019s disease","volume":"380","author":"Egan","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tins.2025.05.007_bb0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00401-016-1577-6","article-title":"Intraneuronal aggregation of the \u03b2-CTF fragment of APP (C99) induces A\u03b2-independent lysosomal-autophagic pathology","volume":"132","author":"Lauritzen","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2025.05.007_bb0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jalz.2019.09.002","article-title":"C99 selectively accumulates in vulnerable neurons in Alzheimer\u2019s disease","volume":"16","author":"Pulina","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2025.05.007_bb0065","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg1925","article-title":"Lysosomal dysfunction in Down syndrome and Alzheimer mouse models is caused by v-ATPase inhibition by Tyr(682)-phosphorylated APP \u03b2CTF","volume":"9","author":"Im","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tins.2025.05.007_bb0070","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.devcel.2024.03.030","article-title":"Accumulation of APP C-terminal fragments causes endolysosomal dysfunction through the dysregulation of late endosome to lysosome-ER contact sites","volume":"59","author":"Bretou","year":"2024","journal-title":"Dev. Cell"},{"key":"10.1016\/j.tins.2025.05.007_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb1717","article-title":"Endosomal recycling reconciles the Alzheimer\u2019s disease paradox","volume":"12","author":"Small","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tins.2025.05.007_bb0080","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00401-014-1379-7","article-title":"Early etiology of Alzheimer\u2019s disease: tipping the balance toward autophagy or endosomal dysfunction?","volume":"129","author":"Peric","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2025.05.007_bb0085","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The Amyloid-\u03b2 pathway in Alzheimer\u2019s disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2025.05.007_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-024-01118-1","article-title":"The duality of amyloid-\u03b2: its role in normal and Alzheimer\u2019s disease states","volume":"17","author":"Azargoonjahromi","year":"2024","journal-title":"Mol. Brain"},{"key":"10.1016\/j.tins.2025.05.007_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0896-6273(03)00205-8","article-title":"Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex","volume":"38","author":"De Strooper","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2025.05.007_bb0100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/34910","article-title":"Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein","volume":"391","author":"De Strooper","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.05.007_bb0105","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/35017105","article-title":"Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells","volume":"2","author":"Herreman","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tins.2025.05.007_bb0110","doi-asserted-by":"crossref","first-page":"33985","DOI":"10.1074\/jbc.M705248200","article-title":"Active gamma-secretase complexes contain only one of each component","volume":"282","author":"Sato","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2025.05.007_bb0115","doi-asserted-by":"crossref","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","article-title":"gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment","volume":"29","author":"Takami","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2025.05.007_bb0120","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1038\/ncomms9762","article-title":"Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer\u2019s disease","volume":"6","author":"Zhang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2025.05.007_bb0125","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature14864","article-title":"\u03b7-Secretase processing of APP inhibits neuronal activity in the hippocampus","volume":"526","author":"Willem","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.05.007_bb0130","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/j.neuron.2024.05.027","article-title":"APP fragment controls both ionotropic and non-ionotropic signaling of NMDA receptors","volume":"112","author":"Dunot","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2025.05.007_bb0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fnmol.2016.00159","article-title":"The metalloprotease meprin \u03b2 is an alternative \u03b2-secretase of APP","volume":"9","author":"Becker-Pauly","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tins.2025.05.007_bb0140","doi-asserted-by":"crossref","first-page":"17768","DOI":"10.1074\/jbc.RA119.008310","article-title":"Phosphorylation of the amyloid precursor protein (APP) at Ser-675 promotes APP processing involving meprin \u03b2","volume":"294","author":"Menon","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2025.05.007_bb0145","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the \u03b2 amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer\u2019s disease","volume":"32","author":"Jarrett","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.tins.2025.05.007_bb0150","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cell.2016.05.020","article-title":"Restricted location of PSEN2\/\u03b3-secretase determines substrate specificity and generates an intracellular A\u03b2 Pool","volume":"166","author":"Sannerud","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.05.007_bb0155","doi-asserted-by":"crossref","first-page":"12821","DOI":"10.1074\/jbc.M115.708297","article-title":"Presenilin 1 and Presenilin 2 target \u03b3-secretase complexes to distinct cellular compartments","volume":"291","author":"Meckler","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2025.05.007_bb0160","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0002-9440(10)64463-X","article-title":"Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology","volume":"161","author":"Takahashi","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tins.2025.05.007_bb0165","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00401-010-0679-9","article-title":"Intraneuronal \u03b2-amyloid accumulation and synapse pathology in Alzheimer\u2019s disease","volume":"119","author":"Gouras","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2025.05.007_bb0170","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1523\/JNEUROSCI.5078-05.2006","article-title":"Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system","volume":"26","author":"Almeida","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2025.05.007_bb0175","doi-asserted-by":"crossref","first-page":"20324","DOI":"10.1073\/pnas.0911281106","article-title":"Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide","volume":"106","author":"Hu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2025.05.007_bb0180","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.chembiol.2014.03.014","article-title":"Direct observations of amyloid \u03b2 self-assembly in live cells provide insights into differences in the kinetics of A\u03b2(1-40) and A\u03b2(1-42) aggregation","volume":"21","author":"Esbj\u00f6rner","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tins.2025.05.007_bb0185","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/emboj.2012.79","article-title":"The mechanism of \u03b3-secretase dysfunction in familial Alzheimer disease","volume":"31","author":"Ch\u00e1vez-Guti\u00e9rrez","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.tins.2025.05.007_bb0190","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1084\/jem.20150892","article-title":"Qualitative changes in human \u03b3-secretase underlie familial Alzheimer\u2019s disease","volume":"212","author":"Szaruga","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tins.2025.05.007_bb0195","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cell.2017.07.004","article-title":"Alzheimer\u2019s-causing mutations shift a\u03b2 length by destabilizing \u03b3-secretase-A\u03b2n interactions","volume":"170","author":"Szaruga","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.05.007_bb0200","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1038\/s41380-022-01518-6","article-title":"A\u03b2 profiles generated by Alzheimer\u2019s disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset","volume":"27","author":"Petit","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2025.05.007_bb0205","doi-asserted-by":"crossref","first-page":"E476","DOI":"10.1073\/pnas.1618657114","article-title":"Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of A\u03b242 and A\u03b240 peptides by \u03b3-secretase","volume":"114","author":"Sun","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2025.05.007_bb0210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.embor.7400897","article-title":"Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease","volume":"8","author":"De Strooper","year":"2007","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tins.2025.05.007_bb0215","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.90690","article-title":"Alzheimer\u2019s disease linked A\u03b242 exerts product feedback inhibition on \u03b3-secretase impairing downstream cell signaling","volume":"12","author":"Zoltowska","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.tins.2025.05.007_bb0220","doi-asserted-by":"crossref","first-page":"10412","DOI":"10.1038\/s41467-024-54777-y","article-title":"Altered expression of Presenilin2 impacts endolysosomal homeostasis and synapse function in Alzheimer\u2019s disease-relevant brain circuits","volume":"15","author":"Perdok","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2025.05.007_bb0225","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00401-012-1062-9","article-title":"Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease","volume":"125","author":"Pera","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2025.05.007_bb0230","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/hmg\/10.16.1665","article-title":"Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability","volume":"10","author":"De Jonghe","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2025.05.007_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101887","article-title":"Dimeric transmembrane orientations of APP\/C99 regulate \u03b3-secretase processing line impacting signaling and oligomerization","volume":"23","author":"Perrin","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.tins.2025.05.007_bb0240","first-page":"75","article-title":"Lowering of amyloid beta peptide production with a small molecule inhibitor of amyloid-\u03b2 precursor protein dimerization","volume":"1","author":"So","year":"2012","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.tins.2025.05.007_bb0245","doi-asserted-by":"crossref","first-page":"12346","DOI":"10.1074\/jbc.M116.723585","article-title":"Structural basis of p75 transmembrane domain dimerization","volume":"291","author":"Nadezhdin","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2025.05.007_bb0250","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1523\/JNEUROSCI.2693-05.2005","article-title":"Acute gamma-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"25","author":"Comery","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2025.05.007_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010943","article-title":"Lowering beta-amyloid levels rescues learning and memory in a Down syndrome mouse model","volume":"5","author":"Netzer","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2025.05.007_bb0260","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.1450-06.2006","article-title":"Synapse formation and function is modulated by the amyloid precursor protein","volume":"26","author":"Priller","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2025.05.007_bb0265","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1523\/JNEUROSCI.2635-08.2008","article-title":"Loss of \u03b3-secretase function impairs endocytosis of lipoprotein particles and membrane cholesterol homeostasis","volume":"28","author":"Tamboli","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2025.05.007_bb0270","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2013.08.056","article-title":"The role of \u03b3-secretase in hippocampal synaptic transmission and activity-dependent synaptic plasticity","volume":"554","author":"Chen","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tins.2025.05.007_bb0275","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/s44318-024-00057-w","article-title":"New precision medicine avenues to the prevention of Alzheimer\u2019s disease from insights into the structure and function of \u03b3-secretases","volume":"43","author":"De Strooper","year":"2024","journal-title":"EMBO J."},{"key":"10.1016\/j.tins.2025.05.007_bb0280","first-page":"219","article-title":"High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice","volume":"149","author":"Fukuchi","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tins.2025.05.007_bb0285","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/exnr.1994.1101","article-title":"Overexpression of a C-terminal portion of the beta-amyloid precursor protein in mouse brains by transplantation of transformed neuronal cells","volume":"127","author":"Fukuchi","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tins.2025.05.007_bb0290","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0006-291X(05)80126-3","article-title":"Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity","volume":"182","author":"Fukuchi","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tins.2025.05.007_bb0295","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70084","article-title":"Amyloid precursor protein and presenilin-1 knock-in immunodeficient mice exhibit intraneuronal A\u03b2 pathology, microgliosis, and extensive neuronal loss","volume":"21","author":"Yeapuri","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2025.05.007_bb0300","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","article-title":"Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer\u2019s disease models and human brains","volume":"141","author":"Vaillant-Beuchot","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2025.05.007_bb0305","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/S0140-6736(20)30689-9","article-title":"Clinical and biomarker changes of Alzheimer\u2019s disease in adults with Down syndrome: a cross-sectional study","volume":"395","author":"Fortea","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.tins.2025.05.007_bb0310","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","article-title":"APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy","volume":"38","author":"Rovelet-Lecrux","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tins.2025.05.007_bb0315","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12879","article-title":"Amyloid precursor protein \u03b2CTF accumulates in synapses in sporadic and genetic forms of Alzheimer\u2019s disease","volume":"49","author":"Ferrer-Ravent\u00f3s","year":"2023","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.tins.2025.05.007_bb0320","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006270","article-title":"Trafficking and proteolytic processing of APP","volume":"2","author":"Haass","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.tins.2025.05.007_bb0325","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1523\/JNEUROSCI.17-01-00140.1997","article-title":"Trafficking of cell-surface beta-amyloid precursor protein: evidence that a sorting intermediate participates in synaptic vesicle recycling","volume":"17","author":"Marquez-Sterling","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2025.05.007_bb0330","doi-asserted-by":"crossref","first-page":"40560","DOI":"10.1074\/jbc.M404345200","article-title":"Presenilins and gamma-secretase inhibitors affect intracellular trafficking and cell surface localization of the gamma-secretase complex components","volume":"279","author":"Wang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2025.05.007_bb0335","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1073\/pnas.1315110110","article-title":"Adaptor complex AP2\/PICALM, through interaction with LC3, targets Alzheimer\u2019s APP-CTF for terminal degradation via autophagy","volume":"110","author":"Tian","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2025.05.007_bb0340","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuron.2019.07.010","article-title":"A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP \u03b2-CTFs, not A\u03b2","volume":"104","author":"Kwart","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2025.05.007_bb0345","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1016\/j.celrep.2018.11.095","article-title":"Altered \u03b3-secretase processing of APP disrupts lysosome and autophagosome function in monogenic Alzheimer\u2019s disease","volume":"25","author":"Hung","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.tins.2025.05.007_bb0350","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1523\/JNEUROSCI.5167-03.2004","article-title":"Oligomerization of Alzheimer\u2019s beta-amyloid within processes and synapses of cultured neurons and brain","volume":"24","author":"Takahashi","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2025.05.007_bb0355","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13024-017-0203-y","article-title":"A\u03b2 accumulation causes MVB enlargement and is modelled by dominant negative VPS4A","volume":"12","author":"Will\u00e9n","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tins.2025.05.007_bb0360","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1016\/S0021-9258(19)39742-X","article-title":"NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor","volume":"265","author":"Chen","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2025.05.007_bb0365","doi-asserted-by":"crossref","first-page":"40353","DOI":"10.1074\/jbc.M104059200","article-title":"Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid","volume":"276","author":"Ando","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2025.05.007_bb0370","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/mp.2015.97","article-title":"Evidence that the rab5 effector APPL1 mediates APP-\u03b2CTF-induced dysfunction of endosomes in Down syndrome and Alzheimer\u2019s disease","volume":"21","author":"Kim","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2025.05.007_bb0375","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1083\/jcb.201201076","article-title":"Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells","volume":"198","author":"Coen","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tins.2025.05.007_bb0380","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1523\/JNEUROSCI.4386-03.2004","article-title":"Dysregulated IP3 signaling in cortical neurons of knock-in mice expressing an Alzheimer\u2019s-linked mutation in presenilin1 results in exaggerated Ca2+ signals and altered membrane excitability","volume":"24","author":"Stutzmann","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2025.05.007_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.900338","article-title":"Inter-organellar Communication in Parkinson\u2019s and Alzheimer\u2019s Disease: Looking Beyond Endoplasmic Reticulum-Mitochondria Contact Sites","volume":"16","author":"Vrijsen","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tins.2025.05.007_bb0390","article-title":"Mitochondrial dysfunction, cause or consequence in neurodegenerative diseases?","volume":"47","author":"Van Acker","year":"2024","journal-title":"Bioessays"},{"key":"10.1016\/j.tins.2025.05.007_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.602116","article-title":"Dysfunctional autophagy and endolysosomal system in neurodegenerative diseases: relevance and therapeutic options","volume":"14","author":"Gioved\u00ec","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tins.2025.05.007_bb0400","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1016\/j.bbamem.2013.04.016","article-title":"A fast growing spectrum of biological functions of \u03b3-secretase in development and disease","volume":"1828","author":"Jurisch-Yaksi","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tins.2025.05.007_bb0405","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","article-title":"The canonical Notch signaling pathway: unfolding the activation mechanism","volume":"137","author":"Kopan","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.05.007_bb0410","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/19083","article-title":"A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain","volume":"398","author":"De Strooper","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.05.007_bb0415","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1126\/science.1058783","article-title":"A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60","volume":"293","author":"Cao","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.tins.2025.05.007_bb0420","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1242\/jcs.01323","article-title":"The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor","volume":"117","author":"von Rotz","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.tins.2025.05.007_bb0425","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.25659","article-title":"Physiological and pathophysiological control of synaptic GluN2B-NMDA receptors by the C-terminal domain of amyloid precursor protein","volume":"6","author":"Pousinha","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.tins.2025.05.007_bb0430","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.bbamcr.2012.05.011","article-title":"The APP intracellular domain (AICD) inhibits Wnt signalling and promotes neurite outgrowth","volume":"1823","author":"Zhou","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tins.2025.05.007_bb0435","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.1471-4159.2007.04627.x","article-title":"Amyloid precursor protein intracellular domain modulates cellular calcium homeostasis and ATP content","volume":"102","author":"Hamid","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2025.05.007_bb0440","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.celrep.2019.08.103","article-title":"The amyloid precursor protein C-terminal domain alters CA1 neuron firing, modifying hippocampus oscillations and impairing spatial memory encoding","volume":"29","author":"Pousinha","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.tins.2025.05.007_bb0445","doi-asserted-by":"crossref","first-page":"18367","DOI":"10.1073\/pnas.0907652106","article-title":"Alzheimer\u2019s disease-like pathological features in transgenic mice expressing the APP intracellular domain","volume":"106","author":"Ghosal","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2025.05.007_bb0450","doi-asserted-by":"crossref","first-page":"24601","DOI":"10.1074\/jbc.M402248200","article-title":"Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation","volume":"279","author":"Cao","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2025.05.007_bb0455","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1046\/j.1471-4159.2001.00516.x","article-title":"The amyloid precursor protein (APP)-cytoplasmic fragment generated by gamma-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture","volume":"78","author":"Cupers","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2025.05.007_bb0460","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1038\/sj.emboj.7600757","article-title":"Amyloid precursor protein promotes post-developmental neurite arborization in the Drosophila brain","volume":"24","author":"Leyssen","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.tins.2025.05.007_bb0465","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1523\/JNEUROSCI.5433-11.2012","article-title":"Novel G\u03b1S-protein signaling associated with membrane-tethered amyloid precursor protein intracellular domain","volume":"32","author":"Deyts","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2025.05.007_bb0470","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrm2745","article-title":"Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function","volume":"10","author":"Saftig","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tins.2025.05.007_bb0475","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1083\/jcb.200301115","article-title":"APP processing is regulated by cytoplasmic phosphorylation","volume":"163","author":"Lee","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tins.2025.05.007_bb0480","doi-asserted-by":"crossref","first-page":"29633","DOI":"10.1074\/jbc.R800003200","article-title":"Regulation of amyloid beta-protein precursor by phosphorylation and protein interactions","volume":"283","author":"Suzuki","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2025.05.007_bb0485","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","article-title":"Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer\u2019s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations","volume":"157","author":"Cataldo","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tins.2025.05.007_bb0490","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-019-0323-7","article-title":"Endo-lysosomal dysregulations and late-onset Alzheimer\u2019s disease: impact of genetic risk factors","volume":"14","author":"Van Acker","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tins.2025.05.007_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105576","article-title":"The role of Alzheimer\u2019s disease risk genes in endolysosomal pathways","volume":"162","author":"Szabo","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2025.05.007_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104511","article-title":"The complex genetic architecture of Alzheimer\u2019s disease: novel insights and future directions","volume":"90","author":"Andrews","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tins.2025.05.007_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109259","article-title":"SORL1 deficiency in human excitatory neurons causes APP-dependent defects in the endolysosome-autophagy network","volume":"35","author":"Hung","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.tins.2025.05.007_bb0510","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/brain\/awae092","article-title":"APP antisense oligonucleotides reduce amyloid-\u03b2 aggregation and rescue endolysosomal dysfunction in Alzheimer\u2019s disease","volume":"147","author":"Hung","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.tins.2025.05.007_bb0515","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.tins.2025.05.007_bb0520","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1523\/JNEUROSCI.2994-18.2019","article-title":"Differential signaling mediated by ApoE2, ApoE3, and ApoE4 in human neurons parallels Alzheimer\u2019s disease risk","volume":"39","author":"Huang","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2025.05.007_bb0525","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tins.2025.05.007_bb0530","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","article-title":"Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis","volume":"77","author":"Karch","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2025.05.007_bb0535","doi-asserted-by":"crossref","first-page":"102","DOI":"10.15252\/embr.201642738","article-title":"Bin1 and CD2AP polarise the endocytic generation of beta-amyloid","volume":"18","author":"Ubelmann","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tins.2025.05.007_bb0540","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1093\/hmg\/ddw239","article-title":"Partial loss of CALM function reduces A\u03b242 production and amyloid deposition in vivo","volume":"25","author":"Kanatsu","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2025.05.007_bb0545","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12868-016-0288-1","article-title":"Decreasing the expression of PICALM reduces endocytosis and the activity of \u03b2-secretase: implications for Alzheimer\u2019s disease","volume":"17","author":"Thomas","year":"2016","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.tins.2025.05.007_bb0550","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41590-018-0179-y","article-title":"PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing","volume":"19","author":"Gavin","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tins.2025.05.007_bb0555","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1038\/s41467-023-38501-w","article-title":"Phospholipase D3 degrades mitochondrial DNA to regulate nucleotide signaling and APP metabolism","volume":"14","author":"Van Acker","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2025.05.007_bb0560","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/156720512799361583","article-title":"\u03b3-Secretase, apolipoprotein E and cellular cholesterol metabolism","volume":"9","author":"Walter","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.tins.2025.05.007_bb0565","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1016\/j.neuron.2023.07.005","article-title":"Neuronal \u03b3-secretase regulates lipid metabolism, linking cholesterol to synaptic dysfunction in Alzheimer\u2019s disease","volume":"111","author":"Essayan-Perez","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2025.05.007_bb0570","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2025.05.007_bb0575","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40478-023-01578-x","article-title":"Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-\u03b2 accumulation in a mouse model of amyloid pathology","volume":"11","author":"Suelves","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tins.2025.05.007_bb0580","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/ahg.12520","article-title":"Pitfalls of predicting age-related traits by polygenic risk scores","volume":"87","author":"Escott-Price","year":"2023","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.tins.2025.05.007_bb0585","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1002\/alz.13810","article-title":"Cognitively healthy centenarians are genetically protected against Alzheimer\u2019s disease","volume":"20","author":"Tesi","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2025.05.007_bb0590","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1007\/s10571-023-01374-0","article-title":"APP-BACE1 Interaction and intracellular localization regulate A\u03b2 production in iPSC-derived cortical neurons","volume":"43","author":"Roselli","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.tins.2025.05.007_bb0595","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JAD-132543","article-title":"Amyloid-\u03b2 peptides are generated in mitochondria-associated endoplasmic reticulum membranes","volume":"43","author":"Schreiner","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tins.2025.05.007_bb0600","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.15252\/embj.201796797","article-title":"Increased localization of APP-C99 in mitochondria-associated ER membranes causes mitochondrial dysfunction in Alzheimer disease","volume":"36","author":"Pera","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.tins.2025.05.007_bb0605","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.3390\/cells9122552","article-title":"Amyloid \u0392-peptide increases mitochondria-endoplasmic reticulum contact altering mitochondrial function and autophagosome formation in Alzheimer\u2019s disease-related models","volume":"9","author":"Leal","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.tins.2025.05.007_bb0610","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201911104","article-title":"Assembly of \u03b3-secretase occurs through stable dimers after exit from the endoplasmic reticulum","volume":"220","author":"Wouters","year":"2021","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tins.2025.05.007_bb0615","doi-asserted-by":"crossref","first-page":"16772","DOI":"10.1021\/acs.jmedchem.3c01480","article-title":"How modulator binding at the amyloid\u03b2-\u03b3-secretase interface enhances substrate binding and attenuates membrane distortion","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tins.2025.05.007_bb0620","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.3233\/JAD-231258","article-title":"BACE inhibitor clinical trials for Alzheimer\u2019s disease","volume":"101","author":"Watkins","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tins.2025.05.007_bb0625","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0223-24.2024","article-title":"The Icelandic mutation (APP-A673T) is protective against amyloid pathology in vivo","volume":"44","author":"Shimohama","year":"2024","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2025.05.007_bb0630","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/crispr.2021.0085","article-title":"Insertion of the Icelandic mutation (A673T) by prime editing: a potential preventive treatment for familial and sporadic Alzheimer\u2019s disease","volume":"5","author":"Tremblay","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.tins.2025.05.007_bb0635","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41587-022-01334-x","article-title":"Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates","volume":"40","author":"Brown","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tins.2025.05.007_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2024.100016","article-title":"Blarcamesine for the treatment of early Alzheimer\u2019s disease: results from the ANAVEX2-73-AD-004 Phase IIB\/III trial","volume":"12","author":"Macfarlane","year":"2025","journal-title":"J. Prev. Alzheimers Dis."}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016622362500102X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016622362500102X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:32:33Z","timestamp":1762252353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016622362500102X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":128,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S016622362500102X"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2025.05.007","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloid precursor protein carboxy-terminal fragments as catalyzers of endolysosomal dysfunction in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Neurosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tins.2025.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}